✦ LIBER ✦

Early Post-Marketing Pharmacovigilance of BLASTOFERON®: An Interferon Beta 1a Biosimilar

✍ Scribed by M. Kauffman, M. Papouchado, E. Gonzalez, A. Sterin-Prync, A. Vidal, R. Diez, H. Ferro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alemtuzumab versus interferon beta-1a in

✍ Alasdair J Coles; Edward Fox; Anton Vladic; Suzanne K Gazda; Vesna Brinar; Krzys 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 306 KB

Post-marketing of disease modifying drug

✍ M. Trojano; F. Pellegrini; D. Paolicelli; A. Fuiani; G.B. Zimatore; C. Tortorell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 277 KB

0550 A comparison of high-dose, high-fre

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB